Molecular and genetic characterization of MHC deficiency identifies ezh2 as therapeutic target for enhancing immune recognition

Daisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, Gerben Duns, Anja Mottok, Pedro Farinha, Ali Bashashati, Saeed Saberi, Merrill Boyle, Barbara Meissner, Susana Ben-Neriah, Bruce W. Woolcock, Adèle Telenius, Daniel Lai, Matt Teater, Robert Kridel, Kerry J. Savage, Laurie H. Sehn, Ryan D. Morin, Marco A. MarraSohrab P. Shah, Joseph M. Connors, Randy D. Gascoyne, David W. Scott, Ari M. Melnick, Christian Steidl

Research output: Contribution to journalArticlepeer-review

127 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Molecular and genetic characterization of MHC deficiency identifies ezh2 as therapeutic target for enhancing immune recognition'. Together they form a unique fingerprint.

Medicine & Life Sciences